Interpretation and Impact of Real-World Clinical Data for the Practicing Clinician.
Interpretation and Impact of Real-World Clinical Data for the Practicing Clinician.
复制标题
DOI:
10.1007/s12325-018-0805-y
复制
发表时间:
2018-11
影响因子:
3.8
通讯作者:
Skolnik NS
中科院分区:
文献类型:
--
作者:
Blonde L;Khunti K;Harris SB;Meizinger C;Skolnik NS
Real-world studies have become increasingly important in providing evidence of treatment effectiveness in clinical practice. While randomized clinical trials (RCTs) are the “gold standard” for evaluating the safety and efficacy of new therapeutic agents, necessarily strict inclusion and exclusion criteria mean that trial populations are often not representative of the patient populations encountered in clinical practice. Real-world studies may use information from electronic health and claims databases, which provide large datasets from diverse patient populations, and/or may be observational, collecting prospective or retrospective data over a long period of time. They can therefore provide information on the long-term safety, particularly pertaining to rare events, and effectiveness of drugs in large heterogeneous populations, as well as information on utilization patterns and health and economic outcomes. This review focuses on how evidence from real-world studies can be utilized to complement data from RCTs to gain a more complete picture of the advantages and disadvantages of medications as they are used in practice. Funding: Sanofi US, Inc.
登录
查看更多内容
影响因子:
4.8
作者:
Choudhry, Niteesh K.;Isaac, Thomas;Sequist, Thomas D.
通讯作者:
Sequist, Thomas D.
影响因子:
5.8
作者:
Bolli, G. B.;Riddle, M. C.;Home, P. D.
通讯作者:
Home, P. D.
影响因子:
158.5
作者:
Benson, K;Hartz, AJ
通讯作者:
Hartz, AJ
影响因子:
15.8
作者:
Golder S;Loke YK;Bland M
通讯作者:
Bland M
DOI:
10.1056/nejmp1702071
发表时间:
2017-06-29
期刊:
The New England journal of medicine
影响因子:
--
作者:
Chen JH;Asch SM
通讯作者:
Asch SM